Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bone Density/drug effects"" wg kryterium: Temat


Tytuł :
Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years:randomised clinical trial
Autorzy :
Bisgaard, Hans
Vinding, Rebecca Kofod
Stokholm, Jakob
Sevelsted, Astrid
Sejersen, Tobias
Chawes, Bo L
Bønnelykke, Klaus
Thorsen, Jonathan
Howe, Laura D
Krakauer, Martin
Pokaż więcej
Temat :
Infant Nutritional Physiological Phenomena
Infant
Fatty Acids, Omega-3/administration & dosage
Research
Absorptiometry, Photon
Dietary Supplements
Maternal Nutritional Physiological Phenomena
Female
Prenatal Exposure Delayed Effects
Double-Blind Method
Body Mass Index
Pregnancy
Fish Oils/administration & dosage
Bone Development/drug effects
Prenatal Care
Randomized Controlled Trial
Prospective Studies
Journal Article
Adult
Bone Density/drug effects
Humans
Child
Źródło :
Vinding, R K, Stokholm, J, Sevelsted, A, Sejersen, T, Chawes, B L, Bønnelykke, K, Thorsen, J, Howe, L D, Krakauer, M & Bisgaard, H 2018, ' Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years : randomised clinical trial ', BMJ, vol. 362, k3312 . https://doi.org/10.1136/bmj.k3312
Vinding, R K, Stokholm, J, Sevelsted, A, Sejersen, T, Chawes, B L, Bønnelykke, K, Thorsen, J, Howe, L D, Krakauer, M & Bisgaard, H 2018, ' Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years : randomised clinical trial ', BMJ (Clinical research ed.), vol. 362, k3312, pp. 1-9 . https://doi.org/10.1136/bmj.k3312
Opis pliku :
application/pdf
Tytuł :
Antibody-based inhibition of circulating DLK1 protects from estrogen deficiency-induced bone loss in mice
Autorzy :
Figeac, Florence
Andersen, Ditte C.
Nipper Nielsen, Casper A.
Ditzel, Nicholas
Sheikh, Søren P.
Skjødt, Karsten
Kassem, Moustapha
Jensen, Charlotte H.
Abdallah, Basem M.
Pokaż więcej
Temat :
Dlk1
X-Ray Microtomography
Intercellular Signaling Peptides and Proteins/immunology
Antibodies, Neutralizing/therapeutic use
Osteoporosis/prevention & control
Osteoblast
Mice
Pref-1
NIH 3T3 Cells
Flow Cytometry
Animals
Female
Cell Line
Osteoblasts/drug effects
Osteogenesis/drug effects
Bone Resorption/prevention & control
Osteoporosis
Estrogens/deficiency
Osteoclasts/drug effects
Antibodies/therapeutic use
Monoclonal antibody
Osteoclast
Humans
Bone Density/drug effects
Ovariectomy
Źródło :
Figeac, F, Andersen, D C, Nipper Nielsen, C A, Ditzel, N, Sheikh, S P, Skjødt, K, Kassem, M, Jensen, C H & Abdallah, B M 2018, ' Antibody-based inhibition of circulating DLK1 protects from estrogen deficiency-induced bone loss in mice ', Bone, vol. 110, pp. 312-320 . https://doi.org/10.1016/j.bone.2018.02.030
Opis pliku :
application/pdf
Tytuł :
Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia:A 6-Year Prospective Cohort Study
Autorzy :
Shanbhogue, Vikram Vinod
Hansen, Stinus
Jørgensen, Niklas Rye
Beck-Nielsen, Signe Sparre
Pokaż więcej
Temat :
Adolescent
Adult
Aged
Bone Density Conservation Agents/therapeutic use
Bone Density/drug effects
Bone Remodeling/drug effects
Familial Hypophosphatemic Rickets/drug therapy
Female
Fibroblast Growth Factors/metabolism
Humans
Lumbar Vertebrae/drug effects
Male
Middle Aged
Prospective Studies
Young Adult
Źródło :
Shanbhogue, V V, Hansen, S, Jørgensen, N R & Beck-Nielsen, S S 2018, ' Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia : A 6-Year Prospective Cohort Study ', Calcified Tissue International, vol. 102, no. 3, pp. 321–328 . https://doi.org/10.1007/s00223-017-0363-3
Tytuł :
Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
Autorzy :
Hansen, Morten S S
Tencerova, Michaela
Frølich, Jacob
Kassem, Moustapha
Frost, Morten
Pokaż więcej
Temat :
Bone Resorption/chemically induced
endocrine system
Gastric Inhibitory Polypeptide/metabolism
Glucagon-Like Peptide 1/metabolism
Fractures, Bone/chemically induced
Obesity/drug therapy
Incretins/pharmacology
Bone and Bones/cytology
Osteocalcin/metabolism
hormones, hormone substitutes, and hormone antagonists
Osteoclasts/drug effects
Disease Models, Animal
Animals
Insulin/metabolism
Bone Density/drug effects
Glucagon-Like Peptide-1 Receptor/agonists
Humans
digestive, oral, and skin physiology
Osteoblasts/drug effects
Diabetes Mellitus, Type 2/drug therapy
Źródło :
Hansen, M S S, Tencerova, M, Frølich, J, Kassem, M & Frost, M 2018, ' Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 1, pp. 25–37 . https://doi.org/10.1111/bcpt.12850
Opis pliku :
application/pdf
Tytuł :
Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer
Autorzy :
Naveiras, Olaia
Schyrr, Frédérica
Wolfer, Anita
Pasquier, Jérôme
Nicoulaz, Anne-Laure
Lamy, Olivier
Pokaż więcej
Temat :
TBS
Bone marrow microenvironment
Bone marrow adipocytes
Breast cancer
Osteoblast
Febrile neutropenia
Osteoporosis
Chemotherapy
Neutrophil
Anemia
Graded toxicity of chemotherapy
Original Article
Hematopoiesis
Stress hematopoiesis
Trabecular bone score
T-score
Platelet
Absorptiometry, Photon
Adipocytes/drug effects
Adipocytes/immunology
Adipocytes/pathology
Adult
Aged
Antineoplastic Agents/administration & dosage
Antineoplastic Agents/adverse effects
Blood Platelets/drug effects
Blood Platelets/immunology
Blood Platelets/pathology
Body Mass Index
Bone Density/drug effects
Bone Density/immunology
Bone Diseases, Metabolic/complications
Bone Diseases, Metabolic/diagnostic imaging
Bone Diseases, Metabolic/drug therapy
Bone Diseases, Metabolic/immunology
Bone Marrow Cells/drug effects
Bone Marrow Cells/immunology
Bone Marrow Cells/pathology
Breast Neoplasms/complications
Breast Neoplasms/diagnostic imaging
Breast Neoplasms/drug therapy
Breast Neoplasms/immunology
Cell Count
Chemotherapy, Adjuvant
Female
Hematopoiesis/drug effects
Hematopoiesis/immunology
Humans
Lumbar Vertebrae/diagnostic imaging
Lumbar Vertebrae/drug effects
Lumbar Vertebrae/immunology
Lumbar Vertebrae/pathology
Middle Aged
Neutropenia/chemically induced
Neutropenia/diagnostic imaging
Neutropenia/immunology
Neutropenia/pathology
Neutrophils/drug effects
Neutrophils/immunology
Neutrophils/pathology
Osteoblasts/drug effects
Osteoblasts/immunology
Osteoblasts/pathology
Osteoporosis/complications
Osteoporosis/diagnostic imaging
Osteoporosis/drug therapy
Osteoporosis/immunology
Retrospective Studies
Źródło :
Annals of hematology, vol. 97, no. 2, pp. 309-317
Opis pliku :
application/pdf
Tytuł :
Mechanisms of diabetes mellitus-induced bone fragility
Autorzy :
Napoli, Nicola
Chandran, Manju
Pierroz, Dominique D
Abrahamsen, Bo
Schwartz, Ann V
Ferrari, Serge L
Pokaż więcej
Temat :
Accidental Falls/prevention & control
Animals
Bone Density/drug effects
Bone Remodeling/drug effects
Diabetes Mellitus, Type 1/complications
Diabetes Mellitus, Type 2/complications
Fractures, Bone/etiology
Humans
Hyperglycemia/complications
Hypoglycemic Agents/adverse effects
Źródło :
Napoli, N, Chandran, M, Pierroz, D D, Abrahamsen, B, Schwartz, A V, Ferrari, S L & IOF Bone and Diabetes Working Group 2017, ' Mechanisms of diabetes mellitus-induced bone fragility ', Nature Reviews Endocrinology, vol. 13, no. 4, pp. 208–219 . https://doi.org/10.1038/nrendo.2016.153
Tytuł :
Osteoporosebehandling kan pauseres efter individuel vurdering
Osteoporosis treatment can be discontinued based on an individual assessment
Autorzy :
Eiken, Pia Agnete
Abrahamsen, Bo
Pokaż więcej
Temat :
Aged
Biomarkers/analysis
Bone Density Conservation Agents/administration & dosage
Bone Density/drug effects
Bone Remodeling/drug effects
Denosumab/administration & dosage
Diphosphonates/administration & dosage
Humans
Middle Aged
Osteoporosis/drug therapy
Precision Medicine
Teriparatide/administration & dosage
Thiophenes/administration & dosage
Withholding Treatment
Źródło :
Eiken, P A & Abrahamsen, B 2017, ' Osteoporosebehandling kan pauseres efter individuel vurdering ', Ugeskrift for Laeger, bind 179, nr. 4, V05160327, s. 335-342 .

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies